Health Care & Life Sciences » Biotechnology | BioRestorative Therapies Inc.

BioRestorative Therapies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1.70
416.00
628.90
36.40
81.00
111
Cost of Goods Sold (COGS) incl. D&A
105.00
310.50
475.30
258.50
259.30
-
Gross Income
103.30
105.50
153.60
222.20
178.30
-
SG&A Expense
4,648.90
5,028.00
7,324.00
7,575.10
8,196.00
7,518.30
EBIT
4,752.30
4,922.50
7,170.40
7,797.30
8,374.30
7,647.70
Unusual Expense
222.10
84.60
150.10
75.10
17.00
1,648.40
Interest Expense
776.80
749.70
603.00
763.90
1,087.40
3,221.80
Pretax Income
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
Consolidated Net Income
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
Net Income
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
Net Income After Extraordinaries
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
Net Income Available to Common
5,751.20
5,587.60
7,923.50
8,636.30
9,444.70
12,517.80
EPS (Basic)
6.96
4.38
3.20
2.10
1.74
1.64
Basic Shares Outstanding
826.30
1,276.90
2,472.90
4,105.80
5,422.40
7,630.10
EPS (Diluted)
6.96
4.38
3.20
2.10
1.74
1.64
Diluted Shares Outstanding
826.30
1,276.90
2,472.90
4,105.80
5,422.40
7,630.10
EBITDA
4,647.50
4,825.80
6,956.60
7,538.80
8,115.00
7,407.30

About BioRestorative Therapies

View Profile
Address
40 Marcus Drive
Melville New York 11747
United States
Employees -
Website http://www.biorestorative.com
Updated 07/08/2019
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.